Surgical treatment of bone metastases in patients with lung cancer

Int Orthop. 2011 May;35(5):731-6. doi: 10.1007/s00264-010-1074-9. Epub 2010 Jun 18.

Abstract

Lung cancer is the leading cause of cancer mortality. Bone metastases are a common complication in lung cancer. The therapeutic approach and the type of surgical treatment of these lesions have not been clearly defined. Outcome and prognosis of patients with bony metastases and a variety of surgical interventions were analysed retrospectively. In 58 patients we performed 62 surgeries. The most common locations of metastases were the spine (32 patients), the proximal femur (10) and the pelvis (11). Twenty-one patients had a singular and 20 had multiple osseous lesions; 17 showed additional visceral involvement. Nine patients had a local progression of their disease and 49 a systemic progression. Patients with local progression (n = 9) had a better prognosis than the patients with systemic progression (p = 0.0083). Fracture (p = 0.0017) worsened prognosis, whereas the number of bone lesions or the presence of a visceral lesion did not. Patients with small lesions showed a better survival than patients with large lesions (p = 0.02). Ten percent of the patients died within 30 days and 78% within one year after surgery. Fracture of bone due to metastatic lung cancer worsens the prognosis whereas the number of bone lesions, the presence of a visceral lesion and the surgical approach do not.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Bone Neoplasms / complications
  • Bone Neoplasms / secondary*
  • Bone Neoplasms / surgery*
  • Combined Modality Therapy
  • Disease Progression
  • Female
  • Fractures, Bone / complications
  • Fractures, Bone / mortality
  • Fractures, Bone / pathology
  • Humans
  • Kaplan-Meier Estimate
  • Lung Neoplasms / complications
  • Lung Neoplasms / pathology
  • Lung Neoplasms / therapy*
  • Male
  • Middle Aged
  • Palliative Care*
  • Plastic Surgery Procedures / methods*
  • Prognosis
  • Retrospective Studies
  • Survival Rate
  • Young Adult